Literature DB >> 18536520

Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease.

Ragnhild Skogseth1, Ezra Mulugeta, Emma Jones, Clive Ballard, Arvid Rongve, Sabine Nore, Guido Alves, Dag Aarsland.   

Abstract

BACKGROUND: The aim of this study was to explore the relationship between cerebrospinal fluid biomarkers and neuropsychiatric symptoms in people with Alzheimer's disease. Psychosis, agitation, apathy and depression were assessed using standardised measures in 32 patients with mild Alzheimer's disease.
METHODS: The levels of the 42-amino-acid form of beta-amyloid (A beta(1-42)), tau and p-tau (phosphorylated at threonine 181) were quantified using the conventional enzyme-linked immunosorbent assay method.
RESULTS: Our result shows that apathy is significantly correlated with tau and p-tau but not with A beta(1-42). There were no significant correlations between indices of psychosis/agitation,or depression and cerebrospinal fluid A beta(1-42), tau or p-tau concentrations.
CONCLUSION: Our finding suggests that apathy is associated with the level of neurofibrillary tangles in people with mild Alzheimer's disease. In contrast, the overall levels of neurofibrillary tangles or amyloid plaques do not seem to be associated with depression or psychosis, indicating that other brain changes contribute to these symptoms. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536520     DOI: 10.1159/000137671

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  16 in total

1.  Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.

Authors:  Corinne E Fischer; Winnie Qian; Tom A Schweizer; Colleen P Millikin; Zahinoor Ismail; Eric E Smith; Lisa M Lix; Paul Shelton; David G Munoz
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 2.  Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?

Authors:  Paul B Rosenberg; Milap A Nowrangi; Constantine G Lyketsos
Journal:  Mol Aspects Med       Date:  2015-06-03

3.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.

Authors:  Jun Ku Chung; Eric Plitman; Shinichiro Nakajima; M Mallar Chakravarty; Fernando Caravaggio; Philip Gerretsen; Yusuke Iwata; Ariel Graff-Guerrero
Journal:  J Geriatr Psychiatry Neurol       Date:  2015-09-23       Impact factor: 2.680

4.  Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals.

Authors:  Brendan J Guercio; Nancy J Donovan; Andrew Ward; Aaron Schultz; Natacha Lorius; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014-11-10       Impact factor: 2.198

Review 5.  Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments.

Authors:  Fleur Harrison; Liesbeth Aerts; Henry Brodaty
Journal:  Curr Psychiatry Rep       Date:  2016-11       Impact factor: 5.285

6.  Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.

Authors:  Lauren P Wadsworth; Natacha Lorius; Nancy J Donovan; Joseph J Locascio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  Dement Geriatr Cogn Disord       Date:  2012-08-28       Impact factor: 2.959

7.  Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum.

Authors:  Nancy J Donovan; Lauren P Wadsworth; Natacha Lorius; Joseph J Locascio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-24       Impact factor: 4.105

8.  Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia.

Authors:  Gad A Marshall; Jennifer R Gatchel; Nancy J Donovan; Martha C Muniz; Aaron P Schultz; J Alex Becker; Jasmeer P Chhatwal; Bernard J Hanseeuw; Kathryn V Papp; Rebecca E Amariglio; Dorene M Rentz; Reisa A Sperling; Keith A Johnson
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

9.  Psychological well-being and regional brain amyloid and tau in mild cognitive impairment.

Authors:  Stephen T Chen; Prabha Siddarth; Nathan Y Saito; Flori Rueda; Taylor Haight; Linda M Ercoli; Karen J Miller; Helen Lavretsky; Jorge R Barrio; Susan Y Bookheimer; Gary W Small; David A Merrill
Journal:  Am J Geriatr Psychiatry       Date:  2013-03-26       Impact factor: 4.105

10.  Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment.

Authors:  I H G B Ramakers; F R J Verhey; P Scheltens; H Hampel; H Soininen; P Aalten; M Olde Rikkert; M M Verbeek; L Spiru; K Blennow; J Q Trojanowski; L M Shaw; P J Visser
Journal:  Psychol Med       Date:  2012-09-07       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.